Article

An Integrated AI Framework for Targeted Depression Drug Discovery: Leveraging Cheminformatics and Genomics

2025-07-29

Abstract excerpt

<title>Abstract</title> <p>Artificial intelligence and machine learning offer transformative opportunities for drug discovery, particularly in complex psychiatric disorders such as major depressive disorder (MDD). In this study, we introduce a dual-pipeline framework that combines cheminformatics-based compound screening with genomics-informed target discovery. We first constructed a supervised learning pipeline...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eecea419-1796-5d22-9bb2-79c01d5a25ff
DOI: 10.21203/rs.3.rs-6868799/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

An Integrated AI Framework for Targeted Depression Drug Discovery: Leveraging Cheminformatics and GenomicsDOI 10.21203/rs.3.rs-6868799/v1Read

A Comprehensive Review on Deep Learning for Genomics and AI in Drug DiscoverySemantic proximity Read

Translating GWAS Findings Into Therapies For Depression And Anxiety Disorders: Drug Repositioning Using Gene-Set Analyses Reveals Enrichment Of Psychiatric Drug ClassesSemantic proximity Read

AI coupled to pharmacometric modelling to tailor malaria and tuberculosis treatment in AfricaSemantic proximity Read

A novel machine learning-based approach for the computational functional assessment of pharmacogenomic variantsSemantic proximity Read

Computational variant predictors for pharmacogenomics: from evaluation of single alleles to assessment of adverse drug reactions to antidepressants.Semantic proximity Read

Drug target prediction through deep learning functional representation of gene signaturesSemantic proximity Read

Role of Artificial Intelligence in Modern Drug Discovery: A Literature OverviewSemantic proximity Read

Drug Discovery in the Era of Artificial Intelligence: From Target Identification to Clinical TrialsSemantic proximity Read

Unveiling Optimal Molecular Features for hERG Insights with Automatic Machine LearningSemantic proximity Read

Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity Read

Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.Semantic proximity Read

Clinical trials in depression: Integrated collection across EU and US registriesSemantic proximity Read